Lupus clinical trials
387 studies are looking for volunteers right now. Search near you to see which are close by and who can take part.
Or see all lupus studies in TrialFinder. Live data from ClinicalTrials.gov, updated daily.
At a glance
Where the studies are
U.S. states with the most recruiting lupus studies. A study counts once in each state where it has a site.
- New York37
- California36
- Texas34
- Florida32
- North Carolina28
- Maryland22
- Illinois21
- Ohio20
- Pennsylvania20
- Georgia18
- Michigan17
- Tennessee16
Also in China (148), France (60), Spain (32), Germany (25), Australia (23), Brazil (23), Canada (23), Italy (22).
Types of study
Phases 1 to 4 test medicines, from first safety checks to long-term follow-up after approval. Trials of devices and programs have no phase. Observational studies give no study treatment.
- Early phase 131
- Phase 177
- Phase 1 / Phase 234
- Phase 243
- Phase 2 / Phase 31
- Phase 316
- Phase 422
- No phase (devices, programs)44
- Observational119
Recently updated studies
Recruiting lupus studies whose listing changed most recently. Open one in TrialFinder to check if you might qualify.
- RecruitingObservationalNCT07178925
Follow-up Cohort of Patients With Antiphospholipid Syndrome
Ages 18 Years – 75 Years · Rouen, France · University Hospital, Rouen
- RecruitingObservationalNCT06948110
Deciphering the Genetic Architecture of Autoimmune Diseases
Ages 18 Years – 115 Years · Bethesda, Maryland · Lima, Peru · National Human Genome Research Institute (NHGRI)
- RecruitingObservationalNCT01145196
Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
Ages 18 Years – 120 Years · Bethesda, Maryland · National Eye Institute (NEI)
- RecruitingObservationalNCT05567198
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
Ages 18 Years – 120 Years · Bethesda, Maryland · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- RecruitingPhase 1NCT07262983
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
Ages 12 Years – 120 Years · Bethesda, Maryland · National Institute of Allergy and Infectious Diseases (NIAID)
- RecruitingPhase 1NCT06975787
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Ages 18 Years – 60 Years · San Francisco, California · Gainesville, Florida +14 more · Regeneron Pharmaceuticals
- RecruitingPhase 1NCT06613360
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Ages 18 Years – 70 Years · Avondale, Arizona · Tucson, Arizona +21 more · Cullinan Therapeutics Inc.
- RecruitingObservationalNCT00001372
Study of Systemic Lupus Erythematosus
Ages 3 Years – 120 Years · Bethesda, Maryland · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Worth knowing
- Taking part is your choice, and you can stop at any time.
- Each study has rules about who can join. The study team checks them with you before you start.
- Talk to your doctor about whether a study is a good fit for you.